DiaMedica Therapeutics Inc. (DMAC) earnings
DMAC earnings moved a median of +1.07% by the close. Quarterly and annual DMAC reports and results, each read against the price at its own news timestamp. Back to the DMAC overview →
30 measured DMAC earnings events.
Where these DMAC earnings landedvs 28 measured DMAC earnings reactions
| Middle 50% of DMAC earnings reactions | -3.25% to +2.30% |
|---|---|
| Median reaction (to close) | +1.07% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 DMAC earnings events with a measured close landed between -3.25% and +2.30%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026 | Press release | +1.14% | +0.98% | |
| DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | Press release | -1.71% | +1.40% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.71% | +1.40% | |
| DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 | Press release | +3.69% | +1.51% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.36% | -5.18% | |
| DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026 | Press release | +1.16% | +5.35% | |
| DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights | Press release | +0.95% | — | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.95% | — | |
| DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025 | Press release | -1.21% | -4.21% | |
| DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights | Press release | +2.86% | +22.45% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.86% | +22.45% | |
| DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 | Press release | -0.64% | +0.00% | |
| DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights | Press release | +2.56% | +2.30% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.56% | +2.30% | |
| DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025 | Press release | — | -2.54% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -13.17% | |
| DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025 | Press release | -0.18% | +3.70% | |
| DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results | Press release | -0.93% | -3.96% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.93% | -3.96% | |
| DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024 | Press release | -2.29% | -0.92% | |
| DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results | Press release | +2.13% | +2.13% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.13% | +2.13% | |
| DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024 | Press release | +0.00% | -0.29% | |
| DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results | Press release | -5.79% | -3.56% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -5.79% | -3.56% | |
| DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 | Press release | +0.00% | +1.15% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.15% | |
| DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results | Press release | +6.84% | +17.93% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +6.84% | +17.93% | |
| DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023 | Press release | -3.97% | +0.00% |
Keep exploring
More DMAC: analyst actions → · SEC filings → · DMAC overview →